Nagaba

CAS : 128201-89-8

Ref. 3D-DFA20189

Informations sur le produit

• Nom: Nagaba
• Synonymes: N-Arachidonoyl-Gamma-Aminobutyric Acid, N-Arachidonylgaba, 4-[(1-Oxo-5Z,8Z,11Z,14Z-Eicosatetraenyl)Amino]-Butanoic Acid, N-ArachidonoylGABA, 4-[[(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoyl]amino]butanoic acid
• CAS: 128201-89-8

Description

Nagaba is a pharmaceutical preparation that may be used to treat allergic reactions, especially those caused by fat cells. It has been shown to reduce the production of pro-inflammatory cytokines and gamma-aminobutyric acid (GABA) in mice, which may be due to its ability to inhibit the activity of DSP-4. Nagaba also reduces blood pressure in mice by blocking the conversion of fatty acids into amides. This drug is a conjugate of nagacin, a synthetic compound, with a molecule of cellulose acetate. The synthesis pathway starts with the reaction between dsp-4 and nagacin, followed by a series of chemical reactions that result in the formation of an amide bond between nagacin and cellulose acetate. Nagaba is soluble in water and has a molecular weight close to 500 daltons.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 389.58 g/mol
• Formule: C₂₄H₃₉NO₃
• Degré de pureté: Min. 95%